Treating recurrent Bell’s palsy: Would antiviral prophylaxis be useful?

Key Points

• Antiviral prophylaxis may enhance overall clinical outcomes in recurrent Bell's palsy cases, improving patient recovery.
• The analysis highlights a significant reduction in recurrence rates among patients receiving antiviral treatments.
• Assessment was conducted through clinical evaluations of Bell's palsy patients over a specified follow-up period.
• Further research is needed to validate these findings across diverse patient populations and settings.